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ABSTRACT
Objectives: The aim of the study was to assess the concordance between the preoperative endometrial sampling and 
microscopic examination of the hysterectomy specimens in patients surgically treated for atypical endometrial hyperplasia 
and endometrial carcinoma.
Material and methods: We analysed a group of 204 patients, of whom 160 (78.43%) underwent surgical treatment for 
cancer of the corpus uteri and 44 (21.57%) for atypical endometrial hyperplasia. The preoperative diagnosis was based 
on the histological examination of endocervical and endometrial samples obtained by fractional curettage and it was 
compared to the histological findings at hysterectomy. The comparison was made for the basic diagnosis, the histological 
type of the cancer and the grade of tumour differentiation.
Results: When the histological types of cancer diagnosed in endometrial curettage and hysterectomy specimens were com-
pared, the concordance was observed in 134/160 patients (83.75%). The highest concordance was found for endometrioid 
carcinoma (127/148 patients, 85.81%). The grade of tumour differentiation was accurate in 69.31% of patients. The highest 
concordance was for moderately differentiated carcinomas. Of 44 patients who underwent surgical treatment for atypical 
endometrial hyperplasia, the preoperative diagnosis was confirmed by the postoperative histopathological examination 
in 21 patients (47.73%). In 15 patients (34.09%) endometrial cancer was diagnosed at hysterectomy.
Conclusions: In endometrial cancer our findings demonstrate a high level of concordance between the histological diagnosis 
on endometrial curettage and at hysterectomy. Own observations have confirmed that over 30% of patients undergoing 
surgical treatment for atypical endometrial hyperplasia have concurrent endometrial cancer which is determined by surgery.
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INTRODUCTION
Endometrial cancer is the leading cause of female geni-
tal cancer in Poland and other developed countries [1]. In 
Poland, it is the 4th most common cancer among women, 
after breast, lung and skin cancers. In 2010, there were over 
5000 new cases and over 900 endometrial cancer deaths [2]. 
The exact causes of endometrial cancer are not fully under-
stood, but a significant increase in its incidence has been 
observed in the last decade, mostly in women with the triad 
of metabolic disorders manifested as obesity, diabetes and 
hypertension [3]. In such patients the risk is 2.5 to 3 times 
higher than in the general population [4].
Most endometrial pathologies present with abnormal 
uterine bleeding or postmenopausal bleeding per vagina. In 
approximately 15% of the cases, endometrial hyperplasia or 
carcinoma is diagnosed [5]. Abnormal bleeding, especially 
in postmenopausal women, usually makes patients seek 
medical advice which allows fairly prompt detection and 
80% of cases are stage I disease. Five-year survival rates are 
up to 90% [6, 7]. The diagnosis is based on the histological 
examination of endometrial samples. However, discrepancy 
between histological findings before and after surgery is 
well-documented [8–12]. The clinical implications are seri-
ous considering the potential effects on surgical staging 
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decisions and disease outcomes. With a preoperative diag-
nosis of atypical hyperplasia of the endometrium, the scope 
of planned surgical treatment may be inadequate when 
endometrial cancer is ultimately diagnosed at hysterectomy 
[8–10] and that is why accuracy of preoperative histology 
is very important. In cases of a malignant tumour of the 
uterine corpus, pathological findings in the hysterectomy 
specimens usually confirm the preoperative diagnosis. Any 
discrepancies usually concern the histological type and 
grade of endometrial cancer [10–15].
AIM OF THE STUDY
The aim of the study was to assess the concordance 
between the preoperative endometrial sampling and micro-
scopic examination of the hysterectomy specimens in pa-
tients surgically treated for atypical endometrial hyperplasia 
and endometrial cancer of the uterine corpus, concerning 
both the diagnosis of cancer and its grading.
MATERIAL AND METHODS
We performed a retrospective review of clinical and 
pathological data from medical records of 204 patients treat-
ed for endometrial cancer of the uterine corpus or atypical 
endometrial hyperplasia at the 1st Department of Obstetrics 
and Gynaecology, Medical University of Warsaw in the years 
2007–2014. The patients’ ages ranged from 39 to 87 years 
(mean age: 63.8 + 10.9 years) and their characteristics are 
summarized in Table 1. The preoperative diagnosis was 
based on the histological examination of endocervical and 
endometrial samples obtained by fractional curettage and it 
was compared to the histological findings at hysterectomy. 
In patients with a preoperative biopsy finding of atypical 
endometrial hyperplasia total hysterectomy with or without 
bilateral salpingo-oophorectomy was performed. In the 
subgroup with endometrial cancer the surgery was more 
extensive and included total hysterectomy and bilateral 
salpingo-oophorectomy with or without complete pelvic 
and para-aortic lymphadenectomy. In cases of endometrial 
cancer its histological type was assessed. Grading was based 
on the morphological and cytological criteria recommend 
by the WHO, i.e.
 Ū cell pleomorphism;
 Ū cell proliferation and crowding;
 Ū loss of cell cohesiveness;
 Ū ratio of glands to stroma. 
Three grades of tumour differentiation were distin-
guished for endometrioid cancers: well-differentiated or 
low-grade (G1), moderately differentiated (G2) and poorly 
differentiated or high-grade (G3). Less common types such 
as serous carcinoma, clear cell carcinoma, small cell carci-
noma and sarcoma were always classified as poorly dif-
ferentiated (G3).
Statistical analysis employed the chi-square test of inde-
pendence with a cross tabulation and the correlation coef-
ficient for nominal variables. The contingency coefficient 
C was calculated which shows strength of the relationship 
between variables as values from 0 to 1, where 0 means no 
association and 1 — a very strong association.
RESULTS
Of 204 patients included in the study, 160 (78.43%) 
underwent surgical treatment for endometrial cancer of 
the uterine corpus and 44 (21.57%) for atypical endome-
trial hyperplasia. The comparison of prehysterectomy and 
hysterectomy findings is presented in Table 2.
Patients with a preoperative diagnosis of 
endometrioid cancer 
Based on the histological examination of endometrial 
samples obtained by curettage, endometrioid cancer was 
the most common type of cancer diagnosed preoperatively 
(148/160 patients, 92.50%), followed by serous carcinoma 
(10/160 patients, 6.25%) and clear cell carcinoma (2/160 pa-
tients, 1.25%).
When the histological types of cancer diagnosed in 
curettage and hysterectomy specimens were compared, the 
concordance was observed in 134/160 patients (83.75%). 
The highest concordance level was found for endometrioid 
cancer (127/148 patients, 85.81%) while serous carcinoma 
was confirmed in 6/10 patients (60%) and clear cell carci-
noma in 1/2 patients (50%).
Statistical analysis demonstrated the concordance 
between the initial and final diagnoses for all histologi-
cal types of endometrial cancer. There was a significant 
association between the two assessments: Chi2 (df = 14; 
n = 160) = 56.11; p = 0.000. The strength of association was 
moderate (C = 0.509).
Subsequently the concordance between grading at cu-
rettage and at hysterectomy was examined. Of 160 patients 
Table 1. Characteristics of the study population
Study group n = 204 (100%)
BMI
 (< 18.5) 3 (1.47%)
 (18.5–24.99) 45 (22.06%)
 (25.0–29.99) 61 (29.90%)
 ≥ 30.0 95 (46.57%)
Parity Nulliparous 38 (18.63%)
P1 61 (29.90%)
P ≥ 2 105 (51.47%)
Hypertension 141 (69.12%)
Diabetes 37 (18.14%)
 BMI — body mass index
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with cancer diagnosed in endometrial samples, the histo-
logical grade was classified in 101 (63.12%), but not in the 
remaining 59 patients (36.88%). In this group of patients, 
G2 (moderately differentiated carcinoma) was the most 
commonly identified grade (62/ 101 patients, 61.39%) while 
G1 and G3 disease was found in 9/101 patients (8.9%) and 
30/101 patients (29.7%) respectively. Histological grading at 
hysterectomy was performed for all patients with diagnosed 
endometrial cancer. Similarly, moderately differentiated 
cancers were the most commonly identified tumours, in 
117/170 patients (68.82%). G1 and G3 disease was found in 
15/170 (8.82%) and 38/170 patients (22.36%) respectively.
In 70/101 patients (69.31%) the grade identified in the hys-
terectomy specimens was the same as diagnosed from sam-
pling. The lowest concordance level was for well-differentiated 
carcinomas. It was 11.11% which means that in 1/9 cases the 
initial diagnosis was confirmed by the histological examination 
of the hysterectomy specimen. In cases of moderately and 
poorly differentiated cancers the concordance levels were 
high, 75.81% (47/62) and 73.33% (22/30) for G2 and G3 dis-
ease respectively. Statistical analysis demonstrated the con-
cordance of grading between the biopsy specimens and the 
hysterectomy specimens. There was a significant association 
between the two assessments: Chi2 (df = 6; n = 101) = 42.56; 
p = 0.000; the contingency coefficient C = 0.5445.
The concordance between the preoperative and the 
hysterectomy findings was analysed in 101 patients with 
the histological type and grade of the tumour assessed 
preoperatively and confirmed in 59/101 patients (58.42%). 
The findings are presented in Table 3. 





















G1 1 3 1 5 0 0 5 15
145
170
G2 6 47 4 49 2 0 9 117
G3 0 4 4 3 1 1 0 13
Serous carcinoma 0 4 5 1 6 0 1 17
Clear cell carcinoma 0 0 3 0 0 1 0  4
Small cell carcinoma 0 1 1 0 0 0 0 2
Myosarcoma 0 2 0 0 0 0 0 2
Atypical hyperplasia 1 0 0 0 1 0 21 23 
Hyperplasia without atypia 0 1 0 0 0 0 4 5
Endometrium 1 0 0 1 0 0 4 6
Total
9 62 18 59
10 2
44  204 148
 160
Table 3. Comparison of endometrial curettage findings and definitive diagnosis determined by surgery in 101 patients with endometrial cancer 
with the histological grade diagnosed on curettage
  Endometrial curettage findings
Hysterectomy specimen
Endometrioid carcinoma Clear cell carcinoma Serous carcinoma
Total
G1 G2 G3 G3 G3
Endometrioid cancer
G1 1 3 1     5
G2 6 47 4   2 59
G3 0 4 4 1 1 10
Clear cell carcinoma G3      3 1   4
Serous carcinoma G3    4  5   6 15
Other types NS 2 4  1   1 8
Total 9 62 18 2 10 101
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Statistical analysis demonstrated the concordance be-
tween the histological types and grades of endometrial can-
cers diagnosed preoperatively and at hysterectomy. There 
was a significant association between the two assessments: 
Chi2 (df = 20; n = 101) = 42.56; p = 0.000; the contingency 
coefficient C = 0.6239913.
Of 148 patients who underwent surgical treatment for en-
dometrioid cancer diagnosed by endometrial sampling, this 
type of cancer was confirmed by the final surgical pathology 
in 127 patients. The grade was assessed in 70/127 patients 
(55.1%). In 52/70 patients there was agreement between 
the endometrial sampling diagnosis and the final surgical 
pathology. The highest concordance level was found for 
moderately differentiated cancer (87.03%, 47/54 patients). 
For poorly differentiated cancer it was 44.4% (4/9 patients) 
and for well-differentiated cancer it was 14.28% (1/7 patients). 
Statistical analysis demonstrated the concordance of grad-
ing between the curettage samples and the hysterectomy 
specimens. There was a significant association between the 
two assessments: Chi2 (df = 4; n = 70) = 12.77; p = 0.01244; 
the contingency coefficient C = 0.3928.
Patients with a preoperative diagnosis  
of atypical hyperplasia of the endometrium
Of 44 patients who underwent surgical treatment for 
atypical hyperplasia of the endometrium, the preoperative 
diagnosis was confirmed by the final surgical pathology in 
21 patients (47.73%). In 15 patients (34.09%) endometrial 
cancer was diagnosed at hysterectomy (14 endometrioid 
cancers and 1 serous carcinoma). In 8 cases the final diag-
nosis did not confirm atypia or endometrial hyperplasia.
DISCUSSION
Cancer of the uterine corpus is most commonly de-
tected in postmenopausal women [16]. In approximately 
80% of patients type 1 cancer is diagnosed, i.e. endo-
metrioid, hormone-dependent carcinoma preceded by 
atypical hyperplasia of the endometrium [6, 7, 16, 17]. 
Unopposed oestrogen effect is a factor responsible for 
neoplasia and the risk for cancer increases in obese women, 
in women experiencing anovulatory cycles or in women 
with preserved uterus on oestrogen-replacement therapy. 
The treatment for cancer of the uterine corpus is mainly 
surgical and preoperative histological examination of en-
dometrial samples is of key importance for the surgical 
management. The extent of surgery and adjuvant therapy 
depends on the microscopic examination to assess the 
histological type and grade of cancer which are impor-
tant prognostic factors. The other predictors are identified 
by the final diagnosis according to the recommended 
surgical-pathological staging [18]. Type II cancer or poorly 
differentiated endometrioid cancer require more extensive 
surgery while identification of well-differentiated cancer 
in endometrial sampling with only superficial invasion 
of the myometrium allows avoidance of regional lymph- 
adenectomy with its potential serious complications 
[19, 20]. However, the final surgical pathology does not 
always confirm the preoperative sampling diagnosis which 
may lead to either too extensive or too limited surgical 
treatment. In the case of poorly differentiated cancers 
identified from the hysterectomy specimens, preserva-
tion of pelvic and para-aortic lymph nodes, even when 
the invasion of the myometrium is superficial, is likely to 
adversely affect the treatment outcome.
According to the literature, the agreement levels be-
tween the endometrial sampling diagnosis and the final 
surgical pathology range from 30 to 60% [10, 11, 13, 15, 21]. 
The highest level of discrepancy is observed for histological 
grading [10, 11, 13, 15, 21].
In our material, in patients undergoing surgical treat-
ment for endometrial cancer, grading was confirmed in 
134/160 patients (83.75%), a higher percentage than in the 
study of Vorgias et al. who confirmed preoperative grading 
in the final surgical pathology in 67.3% of patients [11].
We performed the analysis of preoperative grading ac-
curacy in 101 out of 160 patients with endometrial cancer 
diagnosed by endometrial sampling (cancer grade was not 
established preoperatively in 59 patients). The percentage of 
results which did not satisfy the pathomorphological criteria 
for a correct preoperative assessment is high. The concord-
ance between the preoperative diagnosis and the surgical 
pathology was high for moderately and poorly differentiated 
cancers, 75.81% for G2 and 73.33% for G3. Although G1 dis-
ease was confirmed in only one out of 9 patients (11.11%), 
the overall concordance in tumour grading was confirmed 
for all 101 patients. 
In the group of patients with endometrioid cancer the 
highest agreement level for the tumour grading was found 
for moderately differentiated cancers at 87.03% while for 
poorly differentiated cancers it was just 44.4%. Many au-
thors are of the opinion that the concordance between 
the preoperative tumour grading and its confirmation at 
hysterectomy is inversely proportional to the tumour dif-
ferentiation. The final surgical pathology confirms the initial 
diagnosis least frequently in the case of well-differentiated 
cancers. The concordance level increases with the degree 
of cancer aggressiveness [10–15]. 
The final diagnosis of endometrial cancer in patients 
undergoing surgical treatment for atypical hyperplasia is 
another concern. Atypical hyperplasia of the endometrium is 
an important clinical problem, because when the preopera-
tive diagnosis is reliable, the adnexa may be spared which 
is important in premenopausal women who wish to retain 
the ovaries or in grossly obese patients for whom vaginal 
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hysterectomy without salpingo-oophorectomy is the sim-
plest and least invasive procedure. In our material, there was 
a high percentage of cancers, mostly well-differentiated, 
diagnosed from the hysterectomy specimens in patients 
undergoing surgical treatment for atypical hyperplasia of 
the endometrium (34%). Of 14 patients with endometrioid 
cancer at hysterectomy, none had G3 disease. In the litera-
ture, the rate of initially identified atypical hyperplasia of the 
endometrium which is ultimately diagnosed as endometrial 
carcinoma at hysterectomy is up to 59% [8, 10, 22]. In the 
GOG study, of 115 patients undergoing surgical treatment 
for atypical hyperplasia, endometrial cancer was diagnosed 
in 39.1% [9].
Summing up, accurate histological examination of en-
dometrial samples informs the decision about the surgi-
cal management. Considering the observed differences 
between the endometrial sampling diagnosis and the final 
surgical pathology, in a number of cases the extent of the 
surgery may be inadequate. Lack of concordance in patients 
undergoing surgical treatment for atypical endometrial 
hyperplasia which is diagnosed at hysterectomy as endo-
metrial cancer with different expression of the prognostic 
factors is often seen in clinical practice. In such situation 
simple hysterectomy with salpingo-oophorectomy may not 
meet the current therapeutic standards and surgical staging 
requirements even in 30% of the cases (own data). Accurate 
histological grading based on the endometrial sampling 
is another concern. In a large number of cases (36%), the 
preoperative assessment did not include tumour grading 
which is a limitation of this study. Although for the study 
purposes we could retrospectively reassess the endometrial 
samples after hysterectomy, such approach would not re-
flect the actual diagnostic data a clinician was offered at the 
time of surgery. The differences between the preoperative 
histology and the surgical pathology may also result from 
the lack of representative endometrial samples. Histology 
findings reported in a number of studies indicate underesti-
mation rather than overestimation of the histological grade 
of the tumour [12–15]. One explanation is that pathologists 
may be wary of overdiagnosing cancer with the resulting 
burden of extensive surgery and its potential complications 
for the patient. In our study, precise analysis of the level of 
discrepancy between the histological findings before and 
at hysterectomy was difficult because there was no preop-
erative grading in a large proportion of the study group. 
The recognition of tumour grade, i.e. the degree of its dif-
ferentiation may be difficult and it largely depends on the 
examiner’s experience. Another cause of discrepancy may 
be inadequate information from the clinician collecting 
endometrial samples from the uterine cavity which makes 
accurate diagnosis difficult although the sample amount 
is sufficient.
CONCLUSIONS
In endometrial cancer, our findings demonstrate a high 
level of concordance between the histological diagnosis on 
endometrial curettage and at hysterectomy. Own observa-
tions have confirmed that over 30% of patients undergoing 
surgical treatment for atypical endometrial hyperplasia have 
concurrent well-differentiated endometrial cancer which is 
determined by surgery.
REFERENCES
1. GLOBOCAN 2012. Estimated Cancer Incidence, Mortality and Prevalence 
Worldwide in 2012. International Agency for Research on Cancer. WHO. 
http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
2. Didkowska J, Wojciechowska U, Zatoński W. Nowotwory złośliwe w Pol-
sce w 2011 roku. Centrum Onkologii — Instytut im. Marii Skłodowskiej-
-Curie. Warszawa 2013.
3. Kacalska-Janssen O, Rajtar-Ciosek A, Zmaczyński A, [et al.]. Markers of 
insulin resistance in perimenopausal women with endometrial patho-
logy. Ginekol Pol. 2013, 84, 922–929.
4. Management of endometrial cancer. ACOG Practice Bulletin No. 65. 
American College of Obstetricians and Gynecologist. Obstet Gynecol. 
2005, 106, 413–425.
5. Gredmark T, Kvint S, Havel G, [et al.]. Histopathological findings in women 
with postmenopauzal bleeding. BJOG. 1995, 102, 133–136. 
6. Creasman WT, Odicino F, Maisonneuve P, [et al.]. Carcinoma of the corpus 
uteri. Int J Gynaecol Obstet. 2006, 95, 105–143.
7. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: 
a review of their pathology with emphasis on recent advances and 
problematic aspects. Adv Anat Pathol. 2002, 9, 145–184. 
8. Antonsen SL, Ulrich L, Høgdall C, [et al.]. Patients with atypical hyperpla-
sia of the endometrium should be treated in oncological centers. Gynecol 
Oncol. 2012, 125, 124–128.
9. Trimble CL, Kauderer J, Zaino R, [et al.]. Concurrent endometrial carcino-
ma in women with a biopsy diagnosis of atypical endometrial hyperpla-
sia: a Gynecologic Oncology Group study. Cancer. 2006, 106, 812–819.
10. Wang X, Huang Z, Di W, [et al.]. Comparison of D&C and hysterectomy 
pathologic findings in endometrial cancer patients. Arch Gynecol Obstet. 
2005, 272, 136–141. 
11. Vorgias G, Lekka J, Katsoulis M, [et al.]. Diagnostic accuracy of prehyste-
rectomy curettage in determining tumour type and grade in patients 
with endometrial cancer. MedGenMed. 2003, 5, 7. 
12.  Obermair A, Geramou M, Gucer F, [et al.]. Endometrial cancer: accuracy 
of the finding of a well differentiated tumour at dilatation and curettage 
compared to the findings at subsequent hysterectomy. Int J Gynecol 
Cancer. 1999, 9, 383–386. 
13. Prat J. Prognostic parameters of endometrial carcinoma. Human Patho-
logy. 2004, 35, 649–662. 
14. Mitchard J, Hirschowitz L. Concordance of FIGO grade of endometrial 
adenocarcinomas in biopsy and hysterectomy specimens. Histopatho-
logy. 2003, 42, 372–378.
15. Petersen RW, Quinlivan JA, Casper GR, [et al.]. Endometrial adenocarci-
noma — presenting pathology is a poor guide to surgical management. 
Aust N Z J Obstet Gynaecol. 2000, 40, 191–194. 
16. Amant F, Moerman P, Neven P, [et al.]. Endometrial cancer. Lancet. 2005. 
366, 9484, 491–505.
17. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary 
approach. Modern Pathology. 2000, 13, 295–308. 
18. Creasman W. Revised FIGO staging for carcinoma of the endometrium. 
Int J Gynaecol Obstet. 2009,105, 109.
19. Mariani A, Webb MJ, Keeney GL. Low-risk corpus cancer: is lymphadenecto-
my or radiotherapy necessary. Am J Obstet Gynecol. 2000, 182, 1506–1519.
20. Benedetti Panici P, Basile S, Maneschi F, [et al.]. Systemic pelvic lympha-
denectomy vs. no lymphadenectomy in early-stage endometrial carci-
noma: randomized clinical trial. J Natl Cancer Inst. 2008, 100, 1707–1716. 
21. Soothill PW, Alcock CJ, MacKenzie IZ. Discrepancy between curettage 
and hysterectomy histology in patients with stage 1 uterine malignancy. 
Br J Obstet Gynaecol. 1989, 96, 478–481
22. Merisio C, Berretta R, De Ioris A, [et al.]. Endometrial cancer in patients 
with preoperative diagnosis of atypical endometrial hyperplasia. Eur 
J Obstet Gynecol Reprod Biol. 2005, 122, 107–111.
